On the contrary, it has been reported in other studies that the loss of heterozygous SOD2 would aggravate chronic intermittent hypoxia-induced lung inflammation and vascular remodeling through the mtROS-NLRP3 signaling pathway [43]. The gene discussed is NLRP3; the disease is inflammatory response.